• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

斯普拉格-道利大鼠和刘易斯大鼠对苯扎贝特反应的差异:降血脂作用及过氧化物酶体酶的诱导

Differences in the response of Sprague-Dawley and Lewis rats to bezafibrate: the hypolipidemic effect and the induction of peroxisomal enzymes.

作者信息

Pill J, Völkl A, Hartig F, Fahimi H D

机构信息

Medical Research Department, Boehringer Mannheim, FRG.

出版信息

Arch Toxicol. 1992;66(5):327-33. doi: 10.1007/BF01973627.

DOI:10.1007/BF01973627
PMID:1610295
Abstract

The effects of bezafibrate administered at 10 and 50 mg/kg/day for 7 days to male Sprague-Dawley (SD) and Lewis rats were investigated in order to determine the interrelation between the changes in serum and hepatic lipid contents and activities of selected peroxisomal, microsomal and mitochondrial enzymes in the two rat strains. In both strains, bezafibrate effectively reduced serum and hepatic lipids, increased the liver weight, induced a proliferation of peroxisomes, and selectively elevated the activities of carnitine acetyltransferase and of the enzymes of the peroxisomal beta-oxidation system. Moreover, immunoblotting revealed that the drug specifically enhanced the concentration of only those peroxisomal enzymes involved in fatty acid beta-oxidation. The data obtained demonstrate that although the responses initiated by bezafibrate are qualitatively similar in both strains, they differ in their magnitude in a dose-dependent manner, with the Lewis strain exhibiting a more pronounced response than the SD rats. These results show that dose-dependent strain differences as well as the generally known species differences should be taken into account in pharmacological and toxicological evaluations of fibrates in rodents. Furthermore, generalization and extrapolation from rodent studies should be treated with great caution.

摘要

为了确定血清和肝脏脂质含量变化与所选过氧化物酶体、微粒体和线粒体酶活性之间的相互关系,研究了以10和50mg/kg/天的剂量给雄性斯普拉格-道利(SD)大鼠和刘易斯大鼠连续给药7天的苯扎贝特的作用。在这两种品系中,苯扎贝特均能有效降低血清和肝脏脂质,增加肝脏重量,诱导过氧化物酶体增殖,并选择性提高肉碱乙酰转移酶和过氧化物酶体β-氧化系统酶的活性。此外,免疫印迹显示该药物仅特异性增强参与脂肪酸β-氧化的那些过氧化物酶体酶的浓度。所获得的数据表明,虽然苯扎贝特引发的反应在两种品系中性质相似,但它们在剂量依赖性方面存在程度差异,刘易斯品系的反应比SD大鼠更为明显。这些结果表明,在对啮齿动物进行贝特类药物的药理学和毒理学评估时,应考虑剂量依赖性品系差异以及普遍已知的物种差异。此外,从啮齿动物研究进行的归纳和推断应极为谨慎。

相似文献

1
Differences in the response of Sprague-Dawley and Lewis rats to bezafibrate: the hypolipidemic effect and the induction of peroxisomal enzymes.斯普拉格-道利大鼠和刘易斯大鼠对苯扎贝特反应的差异:降血脂作用及过氧化物酶体酶的诱导
Arch Toxicol. 1992;66(5):327-33. doi: 10.1007/BF01973627.
2
Relationship between plasma lipids and palmitoyl-CoA hydrolase and synthetase activities with peroxisomal proliferation in rats treated with fibrates.贝特类药物治疗的大鼠中血浆脂质与棕榈酰辅酶A水解酶和合成酶活性及过氧化物酶体增殖之间的关系
Br J Pharmacol. 1994 Jun;112(2):551-6. doi: 10.1111/j.1476-5381.1994.tb13109.x.
3
Hepatic microsomal enzyme induction, beta-oxidation, and cell proliferation following administration of clofibrate, gemfibrozil, or bezafibrate in the CD rat.在CD大鼠中给予氯贝丁酯、吉非贝齐或苯扎贝特后肝微粒体酶诱导、β-氧化和细胞增殖情况
Toxicol Appl Pharmacol. 1997 Jan;142(1):143-50. doi: 10.1006/taap.1996.8007.
4
Proliferation of peroxisomes without simultaneous induction of the peroxisomal fatty acid beta-oxidation.过氧化物酶体增殖但未同时诱导过氧化物酶体脂肪酸β氧化。
FEBS Lett. 1990 May 7;264(1):5-9. doi: 10.1016/0014-5793(90)80750-d.
5
Alkylthio acetic acids (3-thia fatty acids)--a new group of non-beta-oxidizable peroxisome-inducing fatty acid analogues--II. Dose-response studies on hepatic peroxisomal- and mitochondrial changes and long-chain fatty acid metabolizing enzymes in rats.烷硫基乙酸(3-硫代脂肪酸)——一类新型的非β-氧化可诱导过氧化物酶体的脂肪酸类似物——II. 对大鼠肝脏过氧化物酶体和线粒体变化以及长链脂肪酸代谢酶的剂量反应研究
Biochem Pharmacol. 1989 Nov 15;38(22):3969-79. doi: 10.1016/0006-2952(89)90676-x.
6
The short- and long-term effects of bezafibrate in the rat.苯扎贝特对大鼠的短期和长期影响。
Ann N Y Acad Sci. 1982;386:111-35. doi: 10.1111/j.1749-6632.1982.tb21410.x.
7
Effect of gemfibrozil on centrifugal behavior of rat peroxisomes and activities of peroxisomal enzymes involved in lipid metabolism.
Biol Pharm Bull. 1997 Apr;20(4):315-21. doi: 10.1248/bpb.20.315.
8
Hypolipidemic effect and enhancement of peroxisomal beta-oxidation in the liver of rats by sodium-(E)-3-(4-(3-pyridylmethyl)phenyl)-2-methyl propenoate (OKY-1581), a potent inhibitor of TxA2 synthetase.强效血栓素A2合成酶抑制剂(E)-3-(4-(3-吡啶甲基)苯基)-2-甲基丙烯酸钠(OKY-1581)对大鼠肝脏的降血脂作用及过氧化物酶体β-氧化的增强作用
J Pharmacobiodyn. 1986 Dec;9(12):1023-31. doi: 10.1248/bpb1978.9.1023.
9
Selective induction of peroxisomal enzymes by the hypolipidemic drug bezafibrate. Detection of modulations by automatic image analysis in conjunction with immunoelectron microscopy and immunoblotting.降血脂药物苯扎贝特对过氧化物酶体酶的选择性诱导作用。结合免疫电子显微镜和免疫印迹法,通过自动图像分析检测调节作用。
Eur J Cell Biol. 1988 Aug;46(3):383-93.
10
Species differences in the effects of bezafibrate, a hypolipidemic agent, on hepatic peroxisome-associated enzymes.降血脂药物苯扎贝特对肝脏过氧化物酶体相关酶作用的种属差异。
Biochem Pharmacol. 1989 Jan 15;38(2):367-71. doi: 10.1016/0006-2952(89)90051-8.

引用本文的文献

1
Novel PPAR pan agonist, ZBH ameliorates hyperlipidemia and insulin resistance in high fat diet induced hyperlipidemic hamster.新型PPAR泛激动剂ZBH改善高脂饮食诱导的高脂血症仓鼠的高脂血症和胰岛素抵抗。
PLoS One. 2014 Apr 23;9(4):e96056. doi: 10.1371/journal.pone.0096056. eCollection 2014.
2
Strain-dependent urethral response.应变依赖性尿道反应。
Neurourol Urodyn. 2011 Nov;30(8):1652-8. doi: 10.1002/nau.21158. Epub 2011 Aug 8.
3
Relationship between plasma lipids and palmitoyl-CoA hydrolase and synthetase activities with peroxisomal proliferation in rats treated with fibrates.

本文引用的文献

1
Microdetermination of plasma phospholipids by trichloroacetic acid precipitation.用三氯乙酸沉淀法微量测定血浆磷脂
J Lab Clin Med. 1950 Jan;35(1):155-60.
2
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
3
A microspectrophotometric method for the determination of cytochrome oxidase.一种测定细胞色素氧化酶的显微分光光度法。
贝特类药物治疗的大鼠中血浆脂质与棕榈酰辅酶A水解酶和合成酶活性及过氧化物酶体增殖之间的关系
Br J Pharmacol. 1994 Jun;112(2):551-6. doi: 10.1111/j.1476-5381.1994.tb13109.x.
J Biol Chem. 1951 Apr;189(2):665-70.
4
THE DISTRIBUTION OF CARNITINE, ACETYLCARNITINE, AND CARNITINE ACETYLTRANSFERASE IN RAT TISSUES.肉碱、乙酰肉碱和肉碱乙酰转移酶在大鼠组织中的分布
J Biol Chem. 1965 May;240:2193-6.
5
A simple method for the isolation and purification of total lipides from animal tissues.一种从动物组织中分离和纯化总脂质的简单方法。
J Biol Chem. 1957 May;226(1):497-509.
6
Specificity in the action of hypolipidemic drugs: increase of peroxisomal beta-oxidation largely dissociated from hepatomegaly and peroxisome proliferation in the rat.降血脂药物作用的特异性:大鼠过氧化物酶体β-氧化的增加与肝肿大和过氧化物酶体增殖基本无关。
J Lipid Res. 1982 Feb;23(2):317-26.
7
The short- and long-term effects of bezafibrate in the rat.苯扎贝特对大鼠的短期和长期影响。
Ann N Y Acad Sci. 1982;386:111-35. doi: 10.1111/j.1749-6632.1982.tb21410.x.
8
Effects of clofibrate, bezafibrate, fenofibrate and probucol on plasma lipolytic enzymes in normolipaemic subjects.氯贝丁酯、苯扎贝特、非诺贝特及普罗布考对血脂正常受试者血浆脂解酶的影响。
Eur J Clin Pharmacol. 1983;25(1):57-63. doi: 10.1007/BF00544015.
9
Quantitative microscopy comparison of peroxisome proliferation by the lipid-regulating agent gemfibrozil in several species.脂质调节药物吉非贝齐在多个物种中引发过氧化物酶体增殖的定量显微镜比较
Hepatology. 1984 May-Jun;4(3):520-30. doi: 10.1002/hep.1840040328.
10
Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans.肝脏过氧化物酶体增殖剂致癌作用:降血脂药物和工业增塑剂对人类风险的评估
Crit Rev Toxicol. 1983;12(1):1-58. doi: 10.3109/10408448309029317.